← All stocks

Oruka Therapeutics, Inc.

ORKA Mostly scheduled

CIK 0000907654 #1126 in the set updated 22 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$10.42M

$104.63K on a plan · $9.89M straight out of an exercise

Sold at will

$420.84K

3 of 23 sales

Net

−$10.42M

−$420.84K against sales at will

By person

9 insiders · 23 transactions

141×

Lawrence Klein holds 141 times base salary in stock. $87.98M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Lawrence Klein last reported holding, valued at $95.31, the price Common Stock was last bought or sold at on the open market here, on 21 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Klein Lawrence Otto

Chief Executive Officer

—

$7.12M (4) scheduled

−$7.12M

923,128

1.39%

$87.98M

+8.3%

Quinlan Paul T

General Counsel

—

$1.04M (5) scheduled

−$1.04M

29,995

0.0453%

$2.86M

—

Agarwal Arjun

Senior Vice President, Finance

—

$977.04K (6) scheduled

−$977.04K

14,219

0.0215%

$1.36M

+437.4%

Goncalves Joana

Chief Medical Officer

—

$734.14K (5) scheduled

−$734.14K

31,771

0.0480%

$3.03M

+1,659%

Sandler Laura Lee

Chief Operating Officer

—

$545.81K (3) scheduled

−$545.81K

235,478

0.3557%

$22.44M

+10.5%

Venrock Healthcare Capital Partners III, L.P. entity

10% owner

—

4,148,428

6.27%

$395.39M

+3.1%

Fairmount Funds Management LLC entity

Director

—

1,131,954

1.71%

$107.89M

+77.3%

Edwards Larry Todd

Chief Commercial Officer

—

100,000

0.1510%

$9.53M

—

Dambkowski Carl

Director

—

38,743

0.0585%

$3.69M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Sandler Laura Lee

15 Sep 2026

Chief Operating Officer

Sell

906

$95.71

$86.71K

Quinlan Paul T

15 Sep 2026

General Counsel

Sell

1,039

$95.71

$99.44K

Klein Lawrence Otto

15 Sep 2026

Chief Executive Officer

Sell

2,452

$95.71

$234.68K

Show all 23 transactions →

What was left out

Form 4 filings counted 10

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 18

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 206,459

History held since 21 Sep 2016